Details of the Drug Formulaction | DrugMAP

General Information of Drug Formulation (ID: F07960)

Formulation Name

Fenofibrate 134 mg capsule

Company

Alvogen

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Fenofibrate	DMFKXDY	Coronary atherosclerosis		Approved
--------------------

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Carmellose sodium	E00625	Not Available	Disintegrant
Ferrosoferric oxide	E00231	14789	Colorant
Potassium hydroxide	E00233	14797	Alkalizing agent
Quinoline yellow WS	E00309	24671	Colorant
Silicon dioxide	E00670	Not Available	Anticaking agent; Opacifying agent; Viscosity-controlling agent
Sodium lauryl sulfate	E00464	3423265	Emulsifying agent; Modified-release agent; Penetration agent; Solubilizing agent; Surfactant; lubricant
Sodium stearyl fumarate	E00545	23665634	lubricant
Sunset yellow FCF	E00255	17730	Colorant
Titanium dioxide	E00322	26042	Coating agent; Colorant; Opacifying agent

--------------------